Evotec (UK Sample Clauses

Evotec (UK. Ltd Evotec (UK) Ltd, as a leading industrial application partner, is responsible for four key objectives: adaptation of hierarchical GPCR modelling protocol (HGMP) to HPC platform, developing of the new HGMP-HPC based tools / plugins that require high scale calculations, testing and application of HGMP-HPC integrated technology in real drug discovery cases within the XxX and to make it available to third parties seeking assistance from the XxX and/or from Evotec, and dissemination of the results of this work to our partners in academia and in pharma & biotech companies in order to stimulate follow-on research. Xxxxxx has also published the outcome of this work in peer-reviewed journals and at scientific conferences [14, 15, 16]. Evotec (UK) Ltd has established a close collaboration with UCL (group of Xxxx Xxxxxx Xxxxxxxx-Nicholson). In the framework of this collaboration, they developed computational methodology to rationalize the receptor-ligand binding and drug-candidates’ residence time [17]. This methodology is based on integration between HGMP (Hierarchical GPCR modelling protocol) and FMO-DFTB (novel and rapid quantum mechanical method [16, 18]). The method was tested by Evotec (UK) Ltd and feedback provided (this is ongoing). Evotec will perform the testing and validation of the protocol in its real drug discovery projects [19]. Dissemination and training: Evotec has given keynote presentations at numerous high-profile international conferences: ACS Annual Conference Boston 2018, CBI Annual Meeting Tokyo 2018, RICT 2018 Strasburg (plenary speaker), ACS Annual Conference in Washington (August 2017) and 6th World Congress on Medicinal Chemistry in Milan (June 2017) Evotec (Xxxx Xxxxxxx) provided a training session in the CompBioMed & BioExcel Free-Energy Workshop, London, 31 May 2017; and at the CompBioMed winter school in Barcelona in February 2018 and in February 2019 on the subject of 'Introduction to Computer-Aided Drug Design (CADD) and GPCR Modelling' illustrated by examples from real drug discovery projects. Videos of both these sessions are available via the CompBioMed YouTube channel. Publications: The translation of knowledge was performed by the following four publications, including a book ‘Computational Methods for GPCR Drug Discovery’ recently (2018) published by Springer [20].
AutoNDA by SimpleDocs

Related to Evotec (UK

  • WSIB & LTD An Employee who is receiving benefits under the Workplace Safety and Insurance Act, or under a LTD plan, is not entitled to benefits under a school board’s sick leave and short term disability plan for the same condition unless the employee is on a graduated return to work program then WSIB/LTD remains the first payor. For clarity, where an employee is receiving partial benefits under WSIB/LTD, they may be entitled to receive benefits under the sick leave plan, subject to the circumstances of the specific situation. During the interim period from the date of the injury/incident or illness to the date of the approval by the WSIB/LTD of the claim, the employee may access sick leave and short term leave and disability coverage. A reconciliation of sick leave deductions made and payments provided, will be undertaken by the school board once the WSIB/LTD has adjudicated and approved the claim. In the event that the WSIB/LTD does not approve the claim, the school board shall deal with the absence consistent with the terms of the sick leave and short term leave and disability plans.

  • Vlastnictví Zdravotnické zařízení si ponechá a bude uchovávat Zdravotní záznamy. Zdravotnické zařízení a Zkoušející převedou na Zadavatele veškerá svá práva, nároky a tituly, včetně práv duševního vlastnictví k Důvěrným informacím (ve smyslu níže uvedeném) a k jakýmkoli jiným Studijním datům a údajům.

  • Foreign-Owned Companies in Connection with Critical Infrastructure If Texas Government Code, Section 2274.0102(a)(1) (relating to prohibition on contracts with certain foreign-owned companies in connection with critical infrastructure) is applicable to this Contract, pursuant to Government Code Section 2274.0102, Contractor certifies that neither it nor its parent company, nor any affiliate of Contractor or its parent company, is: (1) majority owned or controlled by citizens or governmental entities of China, Iran, North Korea, Russia, or any other country designated by the Governor under Government Code Section 2274.0103, or (2) headquartered in any of those countries.

  • designated Trademark Clearinghouse If there is a conflict between the terms and conditions of this Agreement and the Trademark Clearinghouse Requirements, the terms and conditions of this Agreement shall control.

  • Knowledge and Scholarship in Special Field Each certificated support person demonstrates a depth and breadth of knowledge of theory and content in the special field. He demonstrates an understanding of a knowledge about common school education and the educational milieu grades K12, and demonstrates the ability to integrate the area of specialty into the total school milieu, to wit:

  • Utilization of Minority Business Enterprises The Contractor shall perform under this Contract in accordance with 45 C.F.R. Part 74; and, as applicable, C.G.S. §§ 4a-60 to 4a-60a and 4a-60g to carry out this policy in the award of any subcontracts.

  • Women- and Minority-Owned Businesses (W/MBE) The Subrecipient will use its best efforts to afford small businesses, minority business enterprises, and women’s business enterprises the maximum practicable opportunity to participate in the performance of this contract. As used in this cataract, the terms “small business” means a business that meets the criteria set forth in section 3(a) of the Small Business Act, as amended (15 U.S.C. 632), and “minority and women’s business enterprise” means a business at lease fifty-one (51) percent owned and controlled by minority group members or women. For the purpose of this definition, “minority group members” are Afro- Americans, Spanish-speaking, Spanish surnamed or Spanish-heritage Americans, Asian-Americans and American Indians. The Subrecipient may rely on written representation by businesses regarding their status as minority and female business enterprises in lieu of an independent investigation.

  • Creative Commons Attribution-Non-Commercial-NoDerivs License The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND) permits use, distribution and reproduction in any medium, provided the original work is properly cited, is not used for commercial purposes and no modifications or adaptations are made. (see below) Use by commercial "for-profit" organizations Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires further explicit permission from Wiley and will be subject to a fee. Further details can be found on Wiley Online Library xxxx://xxxxxxx.xxxxx.xxx/WileyCDA/Section/id-410895.html Other Terms and Conditions:

  • MINORITY AND WOMEN BUSINESS ENTERPRISES The City hereby gives notice that Minority and Women Business Enterprises will be afforded equal opportunities to submit bids in for this contract and will not be discriminated against on the grounds of race, ethnicity, color, sex, religion or national origin in awarding the contract. Technical assistance is available to Minority and Women Business Enterprises through the Texas Tech University Small Business Development Center, 000 Xxxxxxx Xx., #000, Xxxxxxxx X, Xxxxxxx, Xxxxx, 00000, 325-670-0300.

  • Vientisäätely Sitoudut siihen, ettei Apple-ohjelmistoa viedä edelleen suorasti eikä epäsuorasti ulkomaille, ellei tähän ole erikseen annettu lupaa Yhdysvaltain tai sen oikeustoimialueen/niiden oikeustoimialueiden laeissa, jo(i)sta Apple-ohjelmisto on hankittu. Erityisesti Apple-ohjelmistoa ei saa viedä suorasti tai epäsuorasti (a) Yhdysvaltojen vientikiellossa olevaan maahan tai (b) kenellekään U.S. Treasury Departmentin Specially Designated Nationals -luettelossa olevalle tai U.S. Department of Commercen Denied Person’s List- tai Entity List -luetteloissa tai missään muissa rajoitusten alaisten osapuolten luetteloissa olevalle. Apple-ohjelmistoa käyttämällä annat takuun siitä, ettet ole missään tällaisessa maassa tai luettelossa. Takaat myös, että et käytä Apple-ohjelmistoa mihinkään sellaiseen tarkoitukseen, joka on kielletty Yhdysvaltain laissa, mukaan lukien (mutta näihin rajoittumatta) ohjusten, ydinaseiden tai kemiallisten tai biologisten aseiden kehitys, suunnittelu, valmistus tai tuotanto.

Time is Money Join Law Insider Premium to draft better contracts faster.